REVIEW 3 cited by
MARS: Markov Molecular Sampling for Multi-objective Drug Discovery
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
read the original abstract
Searching for novel molecules with desired chemical properties is crucial in drug discovery. Existing work focuses on developing neural models to generate either molecular sequences or chemical graphs. However, it remains a big challenge to find novel and diverse compounds satisfying several properties. In this paper, we propose MARS, a method for multi-objective drug molecule discovery. MARS is based on the idea of generating the chemical candidates by iteratively editing fragments of molecular graphs. To search for high-quality candidates, it employs Markov chain Monte Carlo sampling (MCMC) on molecules with an annealing scheme and an adaptive proposal. To further improve sample efficiency, MARS uses a graph neural network (GNN) to represent and select candidate edits, where the GNN is trained on-the-fly with samples from MCMC. Experiments show that MARS achieves state-of-the-art performance in various multi-objective settings where molecular bio-activity, drug-likeness, and synthesizability are considered. Remarkably, in the most challenging setting where all four objectives are simultaneously optimized, our approach outperforms previous methods significantly in comprehensive evaluations. The code is available at https://github.com/yutxie/mars.
Forward citations
Cited by 3 Pith papers
-
Neural Flow Samplers with Shortcut Models
Neural Flow Shortcut Sampler (NFS2) estimates the partition-function derivative with velocity-driven SMC and Stein control variates, and adds a generalized shortcut consistency loss for few-step sampling.
-
Adopting Reinforcement Learning with Verifiable Rewards for Molecular Generation
LLMol fine-tunes an LLM on simplified SELFIES and uses GRPO with RDKit-derived rewards for targeted molecular generation, but its own benchmark tables contradict the claimed state-of-the-art performance.
-
Graph Neural Networks in Modern AI-aided Drug Discovery
A comprehensive model-centric review of graph neural network methods and applications in AI-aided drug discovery, from molecular representation to synthesis planning.
Discussion (0). Continue with ORCID to comment.